Saudi digital health is forecast to quadruple by 2032

Saudi Arabia's digital health market was estimated at $4.4bn in 2025 and is forecast to grow at 22.6% a year to reach $18.3bn by 2032, according to market research tracking the sector. Government allocation to healthcare information technology and digital transformation has been reported at more than $1.5bn. Growth is attributed to the healthcare transformation programme, the prevalence of chronic disease — diabetes in particular — and adoption of telemedicine and AI-supported clinical tools. The forecast deserves the usual caution. A 22.6% compound annual growth rate sustained for seven years is a strong claim, and market sizing reports of this kind are produced by firms with a commercial interest in the market appearing large. Different houses put quite different numbers on the same territory. The government allocation figure is the more reliable indicator, because it represents committed budget rather than projected demand. More than $1.5bn directed at healthcare IT is a procurement pipeline, and procurement pipelines are what health technology companies sell into. The demand driver is genuine and it is demographic. The chronic disease point is not marketing: Saudi Arabia has one of the higher adult diabetes prevalence rates globally, and diabetes is the condition digital health is best suited to — it requires continuous monitoring, generates a stream of quantitative data, responds to behavioural intervention, and produces expensive complications when poorly managed. A health system facing that disease burden has a direct financial case for remote monitoring and adherence tools that does not depend on any technology narrative. The saving is in avoided amputations, dialysis and admissions. The same is true of the region's road trauma burden and its ageing expatriate-dependent workforce, both of which create demand for care delivery that does not require a hospital visit. Public sector procurement dominates the spending. The UAE healthcare ecosystem was valued at $34bn in FY2024 with per-capita spending of $1,200, and the GCC recorded roughly 400 healthcare transactions between 2021 and April 2025 — 198 in the UAE and 170 in Saudi Arabia — while the venture side of the sector remains comparatively thin. Altibbi 's $44m Series B in 2023 is still the reference point for regional healthtech, and it is described as the likeliest candidate to become the region's first healthtech unicorn. The distribution of that spend is what regional founders are working with. Most large health IT contracts go to international vendors and systems integrators, because a health system procuring a critical clinical system buys from suppliers with comparable deployments already running. Building those first reference deployments regionally is the step that turns a $4.4bn market into a domestic industry, and it is where the sector's next few years of work sit.